Achieving and maintaining long-term optimal improvements in patient-reported symptoms, signs, and quality of life among patients with moderate to severe psoriasis treated with guselkumab: 3-year data from VOYAGE 1

被引：0

作者：

Blauvelt, A. ^{[1
]}

Han, C. ^{[2
]}

Papp, K. A. ^{[3
]}

Griffiths, C. E. ^{[4
]}

Fernandez-Penas, P. ^{[5
,6
]}

Adam, D. N. ^{[7
,8
]}

Philipp, S. ^{[9
]}

Song, M. ^{[10
]}

Shen, Y. -K. ^{[10
]}

Kimball, A. B. ^{[11
]}

机构：

[1] Oregon Med Res Ctr, Portland, OR USA

[2] Janssen Res & Dev LLC, Malvern, PA USA

[3] K Papp Clin Res & Prob Med Res Inc, Waterloo, ON, Canada

[4] Univ Manchester, Salford Royal Hosp, Dermatol Ctr, Manchester, Lancs, England

[5] Univ Sydney, Sydney, NSW, Austria

[6] Westmead Hosp, Sydney, NSW, Austria

[7] Univ Toronto, Ajax, ON, Canada

[8] Prob Med Res, Ajax, ON, Canada

[9] Charite Univ Med Berlin, Dermatol, Berlin, Germany

[10] Janssen Res & Dev LLC, Spring House, PA USA

[11] Harvard Med Sch, Boston, MA 02115 USA

来源：

关键词：

Guselkumab; Psoriasis; VOYAGE;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P107

引用

页码：49 / 49

页数：1